Javascript must be enabled to continue!
Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta‐analysis
View through CrossRef
AbstractBackgroundOptical coherence tomography (OCT) is an adjunct to angiography‐guided coronary stent placement. However, in the absence of dedicated, appropriately powered randomized controlled trials, the impact of OCT on clinical outcomes is unclear.ObjectiveTo conduct a systematic review and meta‐analysis of all available studies comparing OCT‐guided versus angiography‐guided and intravascular ultrasound (IVUS)‐guided coronary stent implantation.MethodsMEDLINE and Cochrane Central were queried from their inception through July 2022 for all studies that sought to compare OCT‐guided percutaneous coronary intervention (PCI) to angiography‐guided and IVUS‐guided PCI. The primary endpoint was minimal stent area (MSA) compared between modalities. Clinical endpoints of interest were all‐cause and cardiovascular mortality, major adverse cardiovascular events (MACE), myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), and stent thrombosis (ST). Risk ratios (RRs) and mean differences (MDs) with their corresponding 95% confidence intervals (CIs) were pooled using a random‐effects model.ResultsThirteen studies (8 randomized control trials and 5 observational studies) enrolling 6312 participants were included. OCT was associated with a strong trend toward increased MSA compared to angiography (MD = 0.36, p = 0.06). OCT‐guided PCI was also associated with a reduction in the incidence of all‐cause mortality [RR = 0.59, 95% CI (0.35, 0.97), p = 0.04] and cardiovascular mortality [RR = 0.41, 95% CI (0.21, 0.80), p = 0.009] compared with angiography‐guided PCI. Point estimates favored OCT relative to angiography in MACE [RR = 0.75, 95% CI (0.47, 1.20), p = 0.22] and MI [RR = 0.75, 95% CI (0.53, 1.07), p = 0.12]. No differences were detected in ST [RR = 0.71, 95% CI (0.21, 2.44), p = 0.58], TLR [RR = 0.71, 95% CI (0.17, 3.05), p = 0.65], or TVR rates [RR = 0.89, 95% CI (0.46, 1.73), p = 0.73]. Compared with IVUS guidance, OCT guidance was associated with a nonsignificant reduction in the MSA (MD = −0.16, p = 0.27). The rates of all‐cause and cardiovascular mortality, MACE, MI, TLR, TVR, or ST were similar between OCT‐guided and IVUS‐guided PCI.ConclusionsOCT‐guided PCI was associated with reduced all‐cause and cardiovascular mortality compared to angiography‐guided PCI. These results should be considered hypothesis generating as the mechanisms for the improved outcomes were unclear as no differences were detected in the rates of TLR, TVR, or ST. OCT‐ and IVUS‐guided PCI resulted in similar post‐PCI outcomes.
Title: Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta‐analysis
Description:
AbstractBackgroundOptical coherence tomography (OCT) is an adjunct to angiography‐guided coronary stent placement.
However, in the absence of dedicated, appropriately powered randomized controlled trials, the impact of OCT on clinical outcomes is unclear.
ObjectiveTo conduct a systematic review and meta‐analysis of all available studies comparing OCT‐guided versus angiography‐guided and intravascular ultrasound (IVUS)‐guided coronary stent implantation.
MethodsMEDLINE and Cochrane Central were queried from their inception through July 2022 for all studies that sought to compare OCT‐guided percutaneous coronary intervention (PCI) to angiography‐guided and IVUS‐guided PCI.
The primary endpoint was minimal stent area (MSA) compared between modalities.
Clinical endpoints of interest were all‐cause and cardiovascular mortality, major adverse cardiovascular events (MACE), myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), and stent thrombosis (ST).
Risk ratios (RRs) and mean differences (MDs) with their corresponding 95% confidence intervals (CIs) were pooled using a random‐effects model.
ResultsThirteen studies (8 randomized control trials and 5 observational studies) enrolling 6312 participants were included.
OCT was associated with a strong trend toward increased MSA compared to angiography (MD = 0.
36, p = 0.
06).
OCT‐guided PCI was also associated with a reduction in the incidence of all‐cause mortality [RR = 0.
59, 95% CI (0.
35, 0.
97), p = 0.
04] and cardiovascular mortality [RR = 0.
41, 95% CI (0.
21, 0.
80), p = 0.
009] compared with angiography‐guided PCI.
Point estimates favored OCT relative to angiography in MACE [RR = 0.
75, 95% CI (0.
47, 1.
20), p = 0.
22] and MI [RR = 0.
75, 95% CI (0.
53, 1.
07), p = 0.
12].
No differences were detected in ST [RR = 0.
71, 95% CI (0.
21, 2.
44), p = 0.
58], TLR [RR = 0.
71, 95% CI (0.
17, 3.
05), p = 0.
65], or TVR rates [RR = 0.
89, 95% CI (0.
46, 1.
73), p = 0.
73].
Compared with IVUS guidance, OCT guidance was associated with a nonsignificant reduction in the MSA (MD = −0.
16, p = 0.
27).
The rates of all‐cause and cardiovascular mortality, MACE, MI, TLR, TVR, or ST were similar between OCT‐guided and IVUS‐guided PCI.
ConclusionsOCT‐guided PCI was associated with reduced all‐cause and cardiovascular mortality compared to angiography‐guided PCI.
These results should be considered hypothesis generating as the mechanisms for the improved outcomes were unclear as no differences were detected in the rates of TLR, TVR, or ST.
OCT‐ and IVUS‐guided PCI resulted in similar post‐PCI outcomes.
Related Results
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract
Introduction
Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...
Novel functionalized and patterned surfaces for cardiovascular applications
Novel functionalized and patterned surfaces for cardiovascular applications
Nowadays, cardiovascular diseases are mainly treated by implantation of a metallic or polymeric mesh, called stent, which maintains the artery widely open. This technique shows ver...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
OPTICAL COHERENCE TOMOGRAPHY-ANGIOGRAPHY, A NEW DIAGNOSTIC AND FOLLOW-UP TOOL FOR GLAUCOMA
OPTICAL COHERENCE TOMOGRAPHY-ANGIOGRAPHY, A NEW DIAGNOSTIC AND FOLLOW-UP TOOL FOR GLAUCOMA
Glaucoma is an optic neuropathy and is one of the leading causes of irreversible blindness worldwide. There are studies on the role of vascular dysfunction in the pathogenesis of g...
Minimum stent area, stent expansion and ultrasonic flow ratio post pci: insights from multivessel talent trial
Minimum stent area, stent expansion and ultrasonic flow ratio post pci: insights from multivessel talent trial
Abstract
Background
Ultrasonic flow ratio (UFR) is a novel method for fast computation of fractional flow reserve (FFR) from int...
Abstract 17285: Impact of Baseline Yellow Plaque Assessed by Coronary Angioscopy on 11-month Vascular Response After Stent Implantation
Abstract 17285: Impact of Baseline Yellow Plaque Assessed by Coronary Angioscopy on 11-month Vascular Response After Stent Implantation
Background:
In-stent yellow plaque (YP) evaluated by coronary angioscopy (CAS) 1 year after stent implantation is associated with the future adverse cardiac event. Howe...
Navigating triple therapy in a high-risk cardiac patient with a covered stent and embolic stroke: A case report
Navigating triple therapy in a high-risk cardiac patient with a covered stent and embolic stroke: A case report
Abstract
Introduction: Covered stents such as the newly emerging FDA approved papyrus stent plays a pertinent role in th...
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
Objectives
To evaluate the efficacy and safety of domestic long biodegradable polymer coated sirolimus eluting stents (Excel stent, Shandong JW) for treatment of ...

